Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
AK1-H5283 | Human | Human Akt1 Protein, His,Strep II Tag |
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Hu-7691 | Hu-7691 | Phase 1 Clinical | Zhejiang University | Neoplasms | Details |
Oxysterols (Intsel Chimos) | Clinical | Centre National De La Recherche Scientifique (Cnrs) | Glioma | Details | |
NTQ-1062 | NTQ1062; NTQ-1062 | Phase 1 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Solid tumours | Details |
MSC-2363318A | M-2698; MSC-2363318A | Merck Serono | Details | ||
BAY-1125976 | BAY-1125976 | Bayer AG | Details | ||
TAS-117 | TAS-117 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd | Solid tumours | Details |
HZB-0071 | HZB-0071 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd | Neoplasms | Details |
Honokiol | HU-002; JRF-101 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Non-alcoholic Fatty Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung | Details |
Triciribine Phosphate | NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 | Phase 2 Clinical | National Cancer Institute | Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms | Details |
Selumetinib sulfate/MK-2206 | Phase 2 Clinical | Astrazeneca Plc, Merck & Co Inc | Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung | Details | |
Uprosertib/Trametinib Dimethyl Sulfoxide | Phase 2 Clinical | Novartis Pharma Ag | Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details | |
Miransertib | MK-7075; ARQ-092 | Phase 2 Clinical | Arqule Inc | Ovarian Neoplasms; Solid tumours; Proteus Infections; Neoplasms; Proteus Syndrome; Lymphoma; Endometrial Neoplasms | Details |
Capivasertib | AZD-5363 | Phase 3 Clinical | Astrazeneca Pharmaceutical Co Ltd | Glioma; Prostatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Thyroid Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Esophageal adenocarcinoma; Lymphoma; Breast Neoplasms; Fallopian Tube Neoplasms; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Carcinoma, Squamous Cell; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Triple Negative Breast Neoplasms; Solid tumours; Liver Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Neoplasms; Hematologic Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Skin Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant | Details |
RX-0301 | RX-0301; WGI-0301; RX-0201改良型; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N | Phase 1 Clinical | Rexahn Pharmaceuticals Inc | Liver Neoplasms; Solid tumours; Neoplasms | Details |
Afuresertib | ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 | Phase 3 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag | Histiocytosis, Langerhans-Cell; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Peritoneal Neoplasms; Solid tumours; Breast Neoplasms; Multiple Myeloma; Neoplasms; Triple Negative Breast Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms | Details |
Ipatasertib Dihydrochloride | RG-7440; GCD-0068; GDC-0068; RO-5532961 | Phase 3 Clinical | Array Biopharma, F. Hoffmann-La Roche Ltd | Hepatic Insufficiency; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Carcinoma, Endometrioid; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Uterine Neoplasms; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Oropharyngeal Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Glioblastoma; Hypopharyngeal Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Cystadenocarcinoma, Serous; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasm, Residual; Head and Neck Neoplasms; Solid tumours | Details |
MK-2206 | MK2206; MK-2206; BIND-2206; NSC-749607 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Peritoneal Neoplasms; Waldenstrom Macroglobulinemia; Neoplasms, Gonadal Tissue; Carcinoma, Squamous Cell; Glioma; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Thymoma; Gallbladder Neoplasms; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Adenocarcinoma, Bronchiolo-Alveolar; Sezary Syndrome; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Leukemia, Myeloid, Chronic-Phase; Colorectal Neoplasms; Bile Duct Neoplasms; Nasopharyngeal Carcinoma; Carcinoma, Adenosquamous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Monocytic, Acute; Breast Neoplasms, Male; Mycosis Fungoides; Carcinoma, Hepatocellular; Leukemia, T-Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Prolymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Lymphoma, Follicular; Lymphoma; Leukemia, Myelomonocytic, Juvenile; Adenocarcinoma, Mucinous; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Intraocula | Details |
Iopofosine I-131 | HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404; 131I-NM-404; CLR-131; (131)I-CLR1404; NM404 | Phase 2 Clinical | University Of Michigan | Sarcoma, Ewing; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Neuroblastoma; Lymphoma, Mantle-Cell; Osteosarcoma; Head and Neck Neoplasms; Brain Neoplasms; Multiple Myeloma; Central Nervous System Neoplasms; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Rhabdomyosarcoma; Lymphoma, B-Cell, Marginal Zone; Solid tumours | Details |
Uprosertib | GSK-795; GSK-2141795; GSK-2141795C; UPB-795 | Phase 2 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute | Solid tumours; Hematologic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Multiple Myeloma; Breast Neoplasms; Lymphoma; Endometrial Neoplasms; Uterine Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Uterine Cervical Neoplasms; Adenocarcinoma | Details |
TIC-10 | ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 | Phase 3 Clinical | Oncoceutics Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Adenomatous Polyps; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Glioma; Colorectal Neoplasms; Gliosarcoma; Diffuse Intrinsic Pontine Glioma; Solid tumours; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Central Nervous System Neoplasms; Thalamic Diseases; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Glioblastoma; Adenomatous Polyposis Coli | Details |
This web search service is supported by Google Inc.